New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
November 30, 2012
12:50 EDTXYLXylem wins contract for AOP technology to treat drinking water in South Korea
Xylem announced that it has won a significant contract to treat municipal drinking water for a new high-tech industrial zone in South Korea. The contract will involve using ultraviolet advanced oxidation process, or AOP, technology for the first time in a municipal drinking water system in the country. The water treatment facility will treat more than 26 million gallons per day, and will be the first step in the development of the new $3B Sihwa Multi-Tech Valley project, a government-backed regional industrial development initiative being implemented by the K-Water municipality. The new hub for the enterprise is due to be completed by 2016, and aims to attract high-tech industries across the IT, chemicals and R&D sectors.
News For XYL From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
July 30, 2015
07:20 EDTXYLXylem sees 2015 adjusted EPS $1.82-$1.87, consensus $1.86
Subscribe for More Information
07:19 EDTXYLXylem reports Q2 adjusted EPS 43c, consensus 43c
Reports Q2 revenue $920M, consensus $923.66M.
July 29, 2015
10:13 EDTXYLXylem awarded $6M rental contract for Panama Canal expansion
Xylem announced it is providing its heavy duty Godwin dewatering pumps to fill the third set of basin locks on the Pacific Ocean sector of the Panama Canal Expansion Program, with 1.7B gallons of water, as part of performance trials for the system prior to its commissioning. The Panama Canal Expansion Program is scheduled for completion in the second quarter of 2016.
July 20, 2015
07:18 EDTXYLXylem execution leads to growing constructive opinion at Canaccord
Canccord said they are clearly growing more constructive on Xylem following several quarters on the sidelines. The firm cited solid execution and operational initiatives that should prove beneficial this year, as well as bolt-on acquisition potential and the company's strong balance sheet. Canaccord maintains its Hold rating and $38 price target on Xylem shares.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use